tirzepatide fda shortage list GLP-1 Drugs: “Re-Confirms” Decision Removing from the Drug FDA to reconsider removal of

Lexaria's DehydraTECH-tirzepatide Oral Capsules Achieve Comparable Levels in Bloodstream as Eli Lillys Injectable Zepbound(R) More consistent accumulation demonstrated in bloodstream over a one-week duration with once-daily DehydraTECH-tirzepatide oral capsules as compared to once-weekly injection of Zepbound As previously announced, oral DehydraTECH-tirzepatide also reduced adverse events by 47% compared to injected Zepbound Lexaria's oral capsules worthy of expanded investigation as a viable alternative to injected tirzepatide

Ketosis & Metabolic Adaptation Some patients on Mounjaro and Wegovy enter a mild state of ketosis due to reduced appetite and lower carbohydrate intake

In the United States, prescribing rules are more flexible

Accessed March 18, 2026.

Shelf-Stable Formula Vegan, non-GMO, gluten-free, dairy-free, and designed for stability without refrigeration

Regulation of gamma-glutamylcysteine synthetase subunit gene expression by the transcription factor Nrf2